Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
16 02 2021
Historique:
pubmed: 2 2 2021
medline: 16 10 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Background When implantable cardioverter defibrillator (ICD) battery is depleted most patients undergo generator replacement (GR) even in the absence of persistent ICD indication. The aim of this study was to assess the incidence of ventricular arrhythmias and the overall prognosis of patients with and without persistent ICD indication undergoing GR. Predictors of 1-year mortality were also analyzed. Methods and Results Patients with structural heart disease implanted with primary prevention ICD undergoing GR were included. Patients were stratified based on the presence/absence of persistent ICD indication (left ventricular ejection fraction ≤35% at the time of GR and/or history of appropriate ICD therapies during the first generator's life). The study included 371 patients (82% male, 40% with ischemic heart disease). One third of patients (n=121) no longer met ICD indication at the time of GR. During a median follow-up of 34 months after GR patients without persistent ICD indication showed a significantly lower incidence of appropriate ICD shocks (1.9% versus 16.2%,

Identifiants

pubmed: 33522246
doi: 10.1161/JAHA.120.018090
pmc: PMC7955330
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e018090

Références

Europace. 2010 Nov;12(11):1564-70
pubmed: 20974768
N Engl J Med. 2014 May 1;370(18):1694-701
pubmed: 24678999
N Engl J Med. 2017 Jul 6;377(1):41-51
pubmed: 28679089
Circulation. 2010 Oct 19;122(16):1553-61
pubmed: 20921437
Circulation. 2014 Jan 28;129(4):422-9
pubmed: 24243857
Circulation. 2014 Dec 23;130(25):2278-86
pubmed: 25301831
J Am Coll Cardiol. 2016 Feb 2;67(4):435-444
pubmed: 26821633
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):136-42
pubmed: 21325209
Int J Cardiol. 2019 Oct 15;293:119-124
pubmed: 31303396
N Engl J Med. 2008 Sep 4;359(10):1009-17
pubmed: 18768944
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006155
pubmed: 30354311
Int J Cardiol. 2019 May 15;283:122-127
pubmed: 30638746
N Engl J Med. 2012 Dec 13;367(24):2275-83
pubmed: 23131066
Europace. 2019 Aug 1;21(8):1211-1219
pubmed: 31329849
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Circulation. 2013 Oct 15;128(16):e240-327
pubmed: 23741058
Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64
pubmed: 23443618
J Am Coll Cardiol. 2008 Jan 22;51(3):288-96
pubmed: 18206738
Card Electrophysiol Clin. 2018 Mar;10(1):137-144
pubmed: 29428135
N Engl J Med. 2004 May 20;350(21):2140-50
pubmed: 15152059
Eur Heart J. 2013 Jan;34(2):130-7
pubmed: 22771679
Heart Rhythm. 2013 Jun;10(6):838-46
pubmed: 23422221
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):488-97
pubmed: 23759471
J Am Heart Assoc. 2014 Nov 10;3(6):e001289
pubmed: 25385346
J Am Heart Assoc. 2021 Feb 16;10(4):e018090
pubmed: 33522246
J Cardiovasc Electrophysiol. 2011 Oct;22(10):1099-104
pubmed: 21489029

Auteurs

Andrea Demarchi (A)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.
Cardiocentro Ticino Lugano Switzerland.

Stefano Cornara (S)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.
Department of Cardiology San Paolo Hospital Savona Italy.

Antonio Sanzo (A)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Simone Savastano (S)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Barbara Petracci (B)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Alessandro Vicentini (A)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Lorenzo Pontillo (L)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.

Enrico Baldi (E)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.

Laura Frigerio (L)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.

Matteo Astuti (M)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.
Department of Cardiology San Paolo Hospital Savona Italy.

Sergio Leonardi (S)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Department of Molecular Medicine Unit of Cardiology Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Italy.
Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Stefano Ghio (S)

Division of Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Luigi Oltrona Visconti (L)

Division of Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Roberto Rordorf (R)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology Fondazione IRCCS Policlinico San Matteo Pavia Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH